[1] Dinh W,Nickl W,Füth R,et al. High sensitive troponin T and heart fatty acid binding protein: novel biomarker in heart failure with normal ejection fraction A cross-sectional study[J]. BMC Cardiovasc Disord,2011,11:41. [2] 陈 键. 血清H-FABP和MPO检测对老年NSTE ACS患者早期诊断及危险分层价值的研究[J].检验医学,2013,28(4):271-275. [3] Niizeki T,Takeishi Y,Arimoto T,et al. Heart-type fatty acid-binding protein is more sensitive than troponin T to detect the ongoing myocardial damage in chronic heart failure patients[J]. J Card Fail,2007,13(2):120-127. [4] Loria V,Leo M,Biasillo G,et al. Biomarkers in acute coronary syndrome [J]. Biomark Insights,2008,3:453-468. [5] Niizeki T,Takeishi Y,Arimoto T, et al. Combination of heart-type fatty acid binding protein and brain natriuretic peptide can reliably risk stratify patients hospitalized for chronic heart failure [J]. Circ J,2005,69(8):922-927. [6] Setsuta K, Seino Y, Kitahara Y,et al. Elevated levels of both cardiomyocyte membrane and myofibril damage markers predict adverse outcomes in patients with chronic heart failure[J]. Circ J,2008,72(4):569-574. [7] Berthiaume JM,Bray MS,McElfresh TA, et al. The myocardial contractile response to physiological stress improves with high saturated fat feeding in heart failure [J]. Am J Physiol Heart Circ Physiol,2010,299(2):H410-H421. [8] Muehlschlegel JD,Perry TE,Liu KY,et al. Heart-type fatty acid binding protein is an independent predictor of death and ventricular dysfunction after coronary artery bypass graft surgery[J]. Anesth Analg,2010,111(5):1101-1109. [9] Viswanathan K,Hall AS,Barth JH.An evidence-based approach to the assessment of heart-type fatty acid binding protein in acute coronary syndrome[J]. Clin Biochem Rev,2012,33(1):3-11. [10] Steen H,Madadi-Schroeder M,Lehrke S,et al. Staged cardiovascular magnetic resonance for differential diagnosis of troponin T positive patients with low likelihood for acute coronary syndrome[J]. J Cardiovasc Magn Reson,2010,12:51.[11] Viswanathan K,Kilcullen N,Morrell C,et al. Heart-type fatty acid-binding protein predicts long-term mortality and re-infarction in consecutive patients with suspected acute coronary syndrome who are troponin-negative[J].J Am Coll Cardiol,2010,55(23):2590-2598. [12] Setsuta K,Seino Y,Ogawa T,et al. Use of cytosolic and myofibril markers in the detection of ongoing myocardial damage in patients with chronic heart failure [J]. Am J Med,2002,113(9):717-722. [13] Haltern G,Peiniger S,Bufe A,et al.Comparison of usefulness of heart-type fatty acid binding protein versus cardiac troponin T for diagnosis of acute myocardial infarction [J].Am J Cardiol,2010,105(1):1-9. [14] Niizeki T,Takeishi Y,Arimoto T,et al. Persistently increased serum concentration of heart-type fatty acid-binding protein predicts adverse clinical outcomes in patients with chronic heart failure [J].Circ J,2008,72(1): 109-114. [15] 伍树芝,邓 胜,秦伟国,等. 联合检测NT-proBNP、H-FABP和cTnI对老年重症心力衰竭患者的临床价值[J]. 检验医学,2014,29(4):312-318. [16] Ishino M,Takeishi Y,Niizeki T,et al. Risk stratification of chronic heart failure patients by multiple biomarkers implications of BNP,H-FABP,and PTX3 [J]. Circ J,2008,72 (11):1800-1805. [17] Al-Hadi HA,William B,Fox KA.Serum level of heart-type fatty acid-binding protein in patients with chronic renal failure [J]. Sultan Qaboos Univ Med J,2009,9(3): 311-314. [18] Akimoto T,Takeishi Y,Shiga R,et al. Progrostic value of evaluated circulating heart-type fatty acid binding protein in patients with congestive heart failure[J]. J Card Fail,2005,11(1):56-60. |